We are live on
!
Find out more
AP
Arlington Partners Portfolio holdings
AUM
$55.4M
1-Year Est. Return
8%
This Fund
S&P 500
This Quarter
Est. Return
+9.68%
1 Year Est. Return
+8%
3 Year Est. Return
+43.69%
5 Year Est. Return
+33.63%
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$56.1M
(+26%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
13.21%
Top 10 Holdings %
Top 10 Hldgs %
59.01%
Holding
422
New
191
Increased
72
Reduced
16
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$2.91M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
+$2.41M |
| 3 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
+$2.28M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$1.74M |
| 5 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expeditors International
EXPD
|
+$1.09M |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$442K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$401K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$398K |
| 5 |
Vanguard Total Bond Market
BND
|
+$201K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Financials | 6.39% |
| 3 | Industrials | 5.95% |
| 4 | Healthcare | 4.85% |
| 5 | Communication Services | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Target
TGT
$66.3B
| $6K | ﹤0.01% |
+29
| New | +$5.43K |
|
352
Automatic Data Processing
ADP
$109B
| $5K | ﹤0.01% |
+29
| New | +$5.03K |
|
353
Air Products & Chemicals
APD
$65.7B
| $5K | ﹤0.01% |
+17
| New | +$4.62K |
|
354
Factset
FDS
$10B
| $5K | ﹤0.01% |
+15
| New | +$4.75K |
|
355
Lam Research
LRCX
$313B
| $5K | ﹤0.01% |
80
| – | – |
|
356
Paychex
PAYX
$43.5B
| $5K | ﹤0.01% |
+51
| New | +$4.7K |
|
357
Invesco S&P SmallCap Energy ETF
PSCE
$93.9M
| $5K | ﹤0.01% |
+167
| New | +$5.03K |
|
358
Under Armour Class C
UA
$2.95B
| $5K | ﹤0.01% |
297
-16
| -5% | -$281 |
|
359
Aflac
AFL
$65.5B
| $4K | ﹤0.01% |
+70
| New | +$3.36K |
|
360
Clorox
CLX
$12B
| $4K | ﹤0.01% |
+23
| New | +$4.43K |
|
361
Eversource Energy
ES
$28.1B
| $4K | ﹤0.01% |
+45
| New | +$3.82K |
|
362
FormFactor
FORM
$6.49B
| $4K | ﹤0.01% |
94
| – | – |
|
363
McDonald's
MCD
$193B
| $4K | ﹤0.01% |
17
-63
| -79% | -$13.5K |
|
364
VF Corp
VFC
$5.91B
| $4K | ﹤0.01% |
+46
| New | +$3.73K |
|
|
KSU
365
DELISTED
Kansas City Southern
KSU
| $4K | ﹤0.01% |
15
| – | – |
|
|
ATVI
366
DELISTED
Activision Blizzard
ATVI
| $4K | ﹤0.01% |
39
-38
| -49% | -$3.57K |
|
367
Emerson Electric
EMR
$81.6B
| $3K | ﹤0.01% |
+30
| New | +$2.58K |
|
368
Polaris
PII
$3.83B
| $3K | ﹤0.01% |
+26
| New | +$3.17K |
|
369
J.M. Smucker
SJM
$13.5B
| $3K | ﹤0.01% |
+20
| New | +$2.36K |
|
370
Baxter International
BAX
$12.8B
| $2K | ﹤0.01% |
+28
| New | +$2.22K |
|
371
ConocoPhillips
COP
$144B
| $2K | ﹤0.01% |
+34
| New | +$1.68K |
|
372
General Mills
GIS
$20.2B
| $2K | ﹤0.01% |
+39
| New | +$2.25K |
|
373
W.W. Grainger
GWW
$64.3B
| $2K | ﹤0.01% |
+6
| New | +$2.32K |
|
|
K
374
DELISTED
Kellanova
K
| $2K | ﹤0.01% |
+32
| New | +$1.79K |
|
375
Novartis
NVS
$302B
| $2K | ﹤0.01% |
+27
| New | +$2.42K |
|
Similar funds
BWA
JRCM
EI
DCI
AA
CAM
OFA
LCM
Arlington Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Arlington Partners held 422 positions worth $273M, up 26% from $217M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Arlington Partners deployed $36.1M of net new capital in Q1 2021, opening 191 new positions and adding to 72 existing holdings. Its largest new stake was Vanguard Russell 2000 ETF: 27,340 shares worth $2.44M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.9% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Varian Medical Systems, Inc., an estimated $442K trimmed.
- Arlington Partners's largest Q1 2021 buy was Vanguard Russell 2000 ETF: 27,340 shares worth $2.44M.
- Arlington Partners added most to Vanguard High Dividend Yield ETF in Q1 2021, an estimated $2.91M increase.
- Arlington Partners's biggest Q1 2021 reduction was Varian Medical Systems, Inc., cutting an estimated $442K.
- Arlington Partners fully exited Expeditors International in Q1 2021, selling an estimated $1.09M.
- Arlington Partners's ten largest holdings make up 59% of its $273M portfolio in Q1 2021.
- Arlington Partners opened 191 new positions and closed 29 in Q1 2021.
- Arlington Partners's portfolio value rose 26% quarter-over-quarter to $273M.
Based on Arlington Partners's 13F filing for Q1 2021, filed 19 Apr 2021.